Derleme
BibTex RIS Kaynak Göster

SARS-CoV-2 ; Enviromental Features of the Virus

Yıl 2020, COVID-19 Özel Sayı, 55 - 64, 30.04.2020
https://doi.org/10.34084/bshr.719160

Öz

In order to find a solution to COVID-19 disease, which is a priority to the whole world, Sars CoV-2 virus is tried to be investigated in every aspect. Sars CoV-2 virus, which is the cause of covid-19 disease, tries to investigate in all points. No drugs and vaccines have been found yet. It is therefore important to prevent further spread of this highly infectious virus. The contamination occurs from person to person and from contaminated surfaces. For this reason, it is an important issue to know how long the virus can survive in different environments. Because; necessary hygiene, disinfection and sterilization measures are evaluated by taking this information into consideration. These aspects of the virus are addressed in this review article and current information on this subject is tried to be presented to the reader.

Kaynakça

  • 1. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181 –192
  • 2. Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 2009;7:439-50
  • 3. Stadler, K., Masignani, V., Eickmann, M., Becker, S., Abrignani, S., Klenk, H. D., Rappuoli, R. SARS-beginning to understand a new virus. Nature Reviews Microbiology. 2003;1(3):209-218.)
  • 4. Kaynak: https://www.niaid.nih.gov/news-events/novel-coronavirus-sarscov2-images).
  • 5. SR Weiss, JL Leibowitz. Coronavirus pathogenesis. Adv Virus Res, 2011;81:85-164
  • 6. (AM Zaki, Boheemen Sv, TM Bestebroer, ADME Osterhaus, RAM Fouchier. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814-20.).
  • 7. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;Feb 24.
  • 8. Bogoch, A. Watts, A. Thomas-Bachli, C. Huber, M.U.G. Kraemer, K. Khan, Pneumonia of unknown etiology in wuhan, China: potential for international spread via commercial air travel. J. Trav. Med March 13 2020;27(2)
  • 9. (Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;102433.)
  • 10. (Chan, JFW, Yuan S, Kok KK. Et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet, 2020;395(10223):514-23.)
  • 11. R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, et al., Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet 395 2020(10224) 565–574)
  • 12. M. Bassetti, A. Vena, D. Roberto Giacobbe, The Novel Chinese Coronavirus (2019-nCoV) Infections: challenges for fighting the storm, Eur. J. Clin. Invest. (2020)e13209
  • 13. M.L. Holshue, C. DeBolt, S. Lindquist, K.H. Lofy, J. Wiesman, H. Bruce, et al., First case of 2019 novel coronavirus in the United States, N. Engl. J. Med. (2020)
  • 14. Q. Li, X. Guan, P. Wu, X. Wang, L. Zhou, Y. Tong, et al., Early transmission dynamics in wuhan, China, of novel coronavirus-infected pneumonia, N. Engl. J. Med. (2020)
  • 15. Wan, J. Shang, R. Graham, R.S. Baric, F. Li, Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS,J. Virol. (2020)
  • 16. (*W.G. Carlos, C.S. Dela Cruz, B. Cao, S. Pasnick, S. Jamil, Novel wuhan (2019-nCoV) coronavirus, Am. J. Respir. Crit. Care Med. 201 (4) (2020)
  • 17. A. Assiri, J.A. Al-Tawfiq, A.A. Al-Rabeeah, F.A. Al-Rabiah, S. Al-Hajjar, A. AlBarrak, et al., Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study, Lancet Infect. Dis. 13 (2013) 752–761.
  • 18. R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, et al., Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet 395 (10224) (2020) 565–574
  • 19. Y. Wan, J. Shang, R. Graham, R.S. Baric, F. Li, Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS, J. Virol. (2020)
  • 20. (Ludvigsson, J. F. (2020). Systematic review of COVID‐19 in children show milder cases and a better prognosis than adults. Acta Paediatrica.)
  • 21. Chen, H., Guo, J., Wang, C., Luo, F., Yu, X., Zhang, W., ... & Liao, J. (2020). Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet, 395(10226), 809-815.)
  • 22. J.A. Otter, C. Donskey, S. Yezli, S. Douthwaite, S.D. Goldenberg, D.J. WeberTransmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination J Hosp Infect, 92 (2016), pp. 235-250)
  • 23. Kampf, G., Todt, D., Pfaender, S., & Steinmann, E. (2020). Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. Journal of Hospital Infection.
  • 24. Ye G, Lin H, Chen L, et al. Environmental contamination of the SARS-CoV-2 in healthcare premises: an urgent call for protection for healthcare workers. medRxiv 2020; published online March 16.).
  • 25. Chin, A., Chu, J., Perera, M., Hui, K., Yen, H. L., Chan, M., ... & Poon, L. (2020). Stability of SARS-CoV-2 in different environmental conditions. medRxiv.).

SARS-CoV-2; Virüsün Çevresel Özellikleri

Yıl 2020, COVID-19 Özel Sayı, 55 - 64, 30.04.2020
https://doi.org/10.34084/bshr.719160

Öz

Tüm Dünya’nın gündeminde olan COVID-19 hastalığına çözüm bulmak adına hastalığının etkeni Sars CoV-2 virüsü her yönüyle araştırılmaya çalışılmaktadır. Henüz bir ilaç ve aşı bulunamadığından oldukça bulaşıcı olan bu virüsün daha fazla yayılmasını önlemek önemlidir. Bulaş insandan insana ve kontamine yüzeylerden olmaktadır. Bu nedenle virüsün hangi çevresel ortamlarda ne kadar süre ile canlı kalabildiği bilinmesi gereken önemli bir konudur. Çünkü gerekli hijyen, dezenfeksiyon ve sterilizasyon önlemleri bu bilgiler ışığında şekillenmektedir. Virüs, bu yönleri bu derleme yazısında ele alınmış ve bu konudaki güncel bilgiler okuyucuya sunulmaya çalışılmıştır.

Kaynakça

  • 1. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181 –192
  • 2. Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 2009;7:439-50
  • 3. Stadler, K., Masignani, V., Eickmann, M., Becker, S., Abrignani, S., Klenk, H. D., Rappuoli, R. SARS-beginning to understand a new virus. Nature Reviews Microbiology. 2003;1(3):209-218.)
  • 4. Kaynak: https://www.niaid.nih.gov/news-events/novel-coronavirus-sarscov2-images).
  • 5. SR Weiss, JL Leibowitz. Coronavirus pathogenesis. Adv Virus Res, 2011;81:85-164
  • 6. (AM Zaki, Boheemen Sv, TM Bestebroer, ADME Osterhaus, RAM Fouchier. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814-20.).
  • 7. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;Feb 24.
  • 8. Bogoch, A. Watts, A. Thomas-Bachli, C. Huber, M.U.G. Kraemer, K. Khan, Pneumonia of unknown etiology in wuhan, China: potential for international spread via commercial air travel. J. Trav. Med March 13 2020;27(2)
  • 9. (Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;102433.)
  • 10. (Chan, JFW, Yuan S, Kok KK. Et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet, 2020;395(10223):514-23.)
  • 11. R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, et al., Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet 395 2020(10224) 565–574)
  • 12. M. Bassetti, A. Vena, D. Roberto Giacobbe, The Novel Chinese Coronavirus (2019-nCoV) Infections: challenges for fighting the storm, Eur. J. Clin. Invest. (2020)e13209
  • 13. M.L. Holshue, C. DeBolt, S. Lindquist, K.H. Lofy, J. Wiesman, H. Bruce, et al., First case of 2019 novel coronavirus in the United States, N. Engl. J. Med. (2020)
  • 14. Q. Li, X. Guan, P. Wu, X. Wang, L. Zhou, Y. Tong, et al., Early transmission dynamics in wuhan, China, of novel coronavirus-infected pneumonia, N. Engl. J. Med. (2020)
  • 15. Wan, J. Shang, R. Graham, R.S. Baric, F. Li, Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS,J. Virol. (2020)
  • 16. (*W.G. Carlos, C.S. Dela Cruz, B. Cao, S. Pasnick, S. Jamil, Novel wuhan (2019-nCoV) coronavirus, Am. J. Respir. Crit. Care Med. 201 (4) (2020)
  • 17. A. Assiri, J.A. Al-Tawfiq, A.A. Al-Rabeeah, F.A. Al-Rabiah, S. Al-Hajjar, A. AlBarrak, et al., Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study, Lancet Infect. Dis. 13 (2013) 752–761.
  • 18. R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, et al., Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet 395 (10224) (2020) 565–574
  • 19. Y. Wan, J. Shang, R. Graham, R.S. Baric, F. Li, Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS, J. Virol. (2020)
  • 20. (Ludvigsson, J. F. (2020). Systematic review of COVID‐19 in children show milder cases and a better prognosis than adults. Acta Paediatrica.)
  • 21. Chen, H., Guo, J., Wang, C., Luo, F., Yu, X., Zhang, W., ... & Liao, J. (2020). Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet, 395(10226), 809-815.)
  • 22. J.A. Otter, C. Donskey, S. Yezli, S. Douthwaite, S.D. Goldenberg, D.J. WeberTransmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination J Hosp Infect, 92 (2016), pp. 235-250)
  • 23. Kampf, G., Todt, D., Pfaender, S., & Steinmann, E. (2020). Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. Journal of Hospital Infection.
  • 24. Ye G, Lin H, Chen L, et al. Environmental contamination of the SARS-CoV-2 in healthcare premises: an urgent call for protection for healthcare workers. medRxiv 2020; published online March 16.).
  • 25. Chin, A., Chu, J., Perera, M., Hui, K., Yen, H. L., Chan, M., ... & Poon, L. (2020). Stability of SARS-CoV-2 in different environmental conditions. medRxiv.).
Toplam 25 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Tıbbi Mikrobiyoloji
Bölüm Derleme
Yazarlar

Elif Özözen Şahin 0000-0002-8873-2884

Mehmet Köroğlu 0000-0001-8101-1104

Yayımlanma Tarihi 30 Nisan 2020
Kabul Tarihi 24 Nisan 2020
Yayımlandığı Sayı Yıl 2020 COVID-19 Özel Sayı

Kaynak Göster

AMA Özözen Şahin E, Köroğlu M. SARS-CoV-2; Virüsün Çevresel Özellikleri. J Biotechnol and Strategic Health Res. Nisan 2020;4:55-64. doi:10.34084/bshr.719160
  • Dergimiz Uluslararası hakemli bir dergi olup TÜRKİYE ATIF DİZİNİ, TürkMedline, CrossREF, ASOS index, Google Scholar, JournalTOCs, Eurasian Scientific Journal Index(ESJI), SOBIAD ve ISIindexing dizinlerinde taranmaktadır. TR Dizin(ULAKBİM), SCOPUS, DOAJ için başvurularımızın sonuçlanması beklenmektedir.